StockChartsAI.com
All Chart Prices Delayed at least 15 minutesBefore accessing this site, you agree that you have read and agree to the disclaimers at the bottom of this page.
Stock Charts AI Power Rank: 9.0
Power Rank trend -> Rising
06/13/2025 16:22:00 EST
CureVac NV (CVAC)
Industry: Biotechnology
Follow @stockchartsai on TwitterPrice Support Resistance
In the past 20 trading days, CVAC has been trading in a range between $4.70 and $3.72 (gray range band). Red lines on the chart represent key resistance levels and Green lines represent key support levels. As the price moves above the lines you will notice they turn green and red if price moves below a line.
CVAC is breaking above top of the recent 20 day range at $4.70 and appears that it could have some more upside. If it enters a yellow zone the trend may be faltering - consider exiting or taking profits. If it enters a red zone on the chart we would exit the position.
Upside / Downside Potential
CureVac NV $CVAC entered a Green zone 42 days ago on the AI powered stock chart. Wall Street analysts have an AVG target price $6.2974, a potential upside of 13.06% from the recent price of 5.57. The stock is trading 2.69% (potential upside) below its 52 week high of $5.72 and 135.02 % (potential downside) above its 52 week low of $2.37 - based on the recent price.
Company Summary
CureVac NV. , a biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA).
News
| SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CVAC, KNW, SOAR, HLGN on Behalf of Shareholders NEW YORK, June 13, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Source: GlobeNewsWire Fri, 13 Jun 2025 13:19:00 -0400 Sentiment: Neutral |
| Top Stock Movers Now: Oracle, Boeing, CureVac, and More U.S. equities were mixed and little changed at midday as another key measure of inflation, the Producer Price Index (PPI), came in lower than expected. The S&P 500 and Nasdaq advanced, while the Dow Jones Industrial Average was lower. Source: Investopedia Thu, 12 Jun 2025 12:05:36 -0400 Sentiment: Negative |
| CureVac Stock Soars on BioNTech Buyout Biotech stock CureVac NV (NASDAQ:CVAC) was last seen up 32.2% at $5.37, after news that BioNTech (BNTX) is acquiring the company in all-stock deal worth $1.25 billion. Source: Schaeffers Research Thu, 12 Jun 2025 11:08:11 -0400 Sentiment: Positive |
| BioNTech Expands mRNA Cancer Portfolio With CureVac $1.25 Billion All-Stock Deal BioNTech SE BNTX on Thursday agreed to acquire CureVac N.V. CVAC in an all-stock transaction. Source: Benzinga Thu, 12 Jun 2025 11:07:51 -0400 Sentiment: Positive |
| BioNTech boosts cancer mRNA pipeline with CureVac acquisition BioNTech (NASDAQ:BNTX) announced that it is acquiring CureVac (NASDAQ:CVAC), a fellow German mRNA vaccine developer, in an all-stock deal valued at approximately $1.25 billion. Under the deal terms, each share of CureVac will be exchanged for about $5.46 worth of BioNTech American Depositary Shares (ADSs), representing a premium of around 55% over CureVac's recent trading price. Source: Proactive Investors Thu, 12 Jun 2025 10:34:56 -0400 Sentiment: Positive |
Technicals 52 Week Hi: 5.72 52 Week Low: 2.37 Beta: 2.491 50 Day MA: 3.7186 200 Day MA: 3.2964 Earnings / Revenue Trends Qtr Earnings Growth YOY: 0 Qtr Revenue Growth YOY: -0.928 Forward PE: 5.2356 Trailing PE: 6.0543